Debio 1562
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Debio 1562, covering 2024-05-17 to 2024-05-17. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHL [Phase 2]